Clinical trials recruiting for ER-Negative Breast Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Datopotamab deruxtecan | 1 |
| Pembrolizumab | 1 |
| Sacituzumab govitecan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 2 |
| Florida | 1 |
| North Carolina | 1 |
Top cities
Boston, Massachusetts 2Danvers, Massachusetts 1Durham, North Carolina 1Miami, Florida 1Newton, Massachusetts 1
Self-screener
Recruiting trials
Related conditions
Trials recruiting for ER-Negative Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
HER2-negative Breast Cancer 57Breast cancer 2239Triple-negative breast cancer 138Metastatic Triple-Negative Breast Carcinoma 18Invasive Breast Cancer 11HER2 Negative Breast Carcinoma 15ER Positive Breast Cancer 12Breast Cancer Female 61
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ER-Negative Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.